Alternative Data for Charles River Laboratories
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 278 | Sign up | Sign up | Sign up |
| Sentiment | 40 | Sign up | Sign up | Sign up |
| Webpage traffic | 175,000 | Sign up | Sign up | Sign up |
| Employee Rating | 62 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 411 | Sign up | Sign up | Sign up |
| Facebook Followers | 22,225 | Sign up | Sign up | Sign up |
| Instagram Followers | 5,523 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 914 | Sign up | Sign up | Sign up |
| X Followers | 9,038 | Sign up | Sign up | Sign up |
| X Mentions | 4 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 4,420 | Sign up | Sign up | Sign up |
| News Mentions | 2 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 31 | Sign up | Sign up | Sign up |
| Linkedin Employees | 14,797 | Sign up | Sign up | Sign up |
About Charles River Laboratories
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support.
| Price | $219.70 |
| Target Price | Sign up |
| Volume | 803,600 |
| Market Cap | $11B |
| Year Range | $134.98 - $223.47 |
| Dividend Yield | 0% |
| PE Ratio | 592.3 |
| Analyst Rating | 7% buy |
| Industry | Biotechnology |
In the news
 |
Here's Why Charles River Laboratories (CRL) is a Great Momentum Stock to BuyJanuary 15 - Yahoo |
 |
Charles River Laboratories International, Inc. (CRL) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 12 - SeekingAlpha |
|
Charles River Laboratories Reports Two Planned Acquisitions; Names Namandje Bumpus as Chief Scientific and Innovation OfficerJanuary 12 - Yahoo |
|
Charles River Laboratories Provides Business UpdatesJanuary 12 - Yahoo |
|
A Look At Charles River Laboratories (CRL) Valuation After Planned CEO Transition And Governance ShiftJanuary 9 - Yahoo |
|
Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession PlanJanuary 7 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 1B | 666M | 339M | 54M | 198M | 2.430 |
| Q2 '25 | 1.03B | 675M | 357M | 52M | 221M | 3.120 |
| Q1 '25 | 984M | 666M | 318M | 25M | 184M | 2.340 |
| Q4 '24 | 1B | 718M | 284M | -216M | -86M | 2.660 |
| Q3 '24 | 1.01B | 661M | 349M | 69M | 210M | 2.590 |
Insider Transactions View All
| LaPlume Joseph W filed to sell 24,116 shares at $157.6. August 20 '25 |
| LaPlume Joseph W filed to sell 24,916 shares at $150. August 8 '25 |
| MASSARO GEORGE filed to sell 5,575 shares at $139.1. May 16 '25 |
| MASSARO GEORGE filed to sell 5,680 shares at $136.3. May 16 '25 |
| MASSARO GEORGE filed to sell 5,599 shares at $137.7. May 16 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Jefferson Shreve |
Jun 23, 25 | Sell | $15K - $50K |
| Jefferson Shreve |
Jun 23, 25 | Buy | $15K - $50K |
| Rob Bresnahan |
Jun 2, 25 | Sell | $1K - $15K |
Read more about Charles River Laboratories (CRL) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Charles River Laboratories
The Market Cap of Charles River Laboratories is $11B.
As of today, Charles River Laboratories' PE (Price to Earnings) ratio is 592.3.
Currently, the price of one share of Charles River Laboratories stock is $219.70.
The CRL stock price chart above provides a comprehensive visual representation of Charles River Laboratories' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Charles River Laboratories shares. Our platform offers an up-to-date CRL stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Charles River Laboratories (CRL) does not offer dividends to its shareholders. Investors interested in Charles River Laboratories should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Charles River Laboratories are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
